Currency in IDR
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 6 | 6 |
| Avg. Estimate | 0 | 0 | 241.45 | 225.36 |
| Low estimate | 0 | 0 | 209.26 | 160.97 |
| High estimate | 0 | 0 | 273.65 | 305.84 |
| Year ago EPS | N/A | N/A | 209.26 | 241.45 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 0 | 0 | 7 | 7 |
| Avg. Estimate | N/A | N/A | 35.15T | 34.3T |
| Low estimate | N/A | N/A | 32.66T | 29.6T |
| High estimate | N/A | N/A | 37.72T | 38.71T |
| Year ago sales | N/A | N/A | 36.21T | 35.15T |
| Sales growth (year/est) | N/A | N/A | -2.90% | -2.40% |
| Earnings history | Invalid Date | Invalid Date | Invalid Date | 31/12/2023 |
|---|
| Est. EPS | N/A | N/A | N/A | 16.1 |
| Actual EPS | N/A | N/A | N/A | 48.29 |
| Difference | N/A | N/A | N/A | 32.19 |
| Surprise % | N/A | N/A | N/A | 199.90% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0 | 0 | 241.45 | 225.36 |
| 7 days ago | 0 | 0 | 243.03 | 226.83 |
| 30 days ago | 0 | 0 | 239.32 | 223.37 |
| 60 days ago | 0 | 0 | 219.69 | 219.69 |
| 90 days ago | 0 | 0 | 220.18 | 220.18 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | MEDC.JK | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | 15.40% | N/A | N/A | N/A |
| Next year | -6.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | -5.90% | N/A | N/A | N/A |
| Past 5 years (per annum) | 112.56% | N/A | N/A | N/A |
